| Literature DB >> 31806972 |
Ying Yao1, Yiteng Zang1, Jing Qu1, Meng Tang1, Ting Zhang1.
Abstract
Metallic nanoparticles (MNPs) are new engineering materials with broad prospects for biomedical applications; thus, their biosafety has drawn great concern. The liver is the main detoxification organ of vertebrates. However, many issues concerning the interactions between MNPs and biological systems (cells and tissues) are unclear, particularly the toxic effects of MNPs on hepatocytes and other liver cells. Numerous researchers have shown that some MNPs can induce decreased cell survival rate, production of reactive oxygen species (ROS), mitochondrial damage, DNA strand breaks, and even autophagy, pyroptosis, apoptosis, or other forms of cell death. Our review focuses on the recent researches on the liver toxicity of MNPs and its mechanisms at cellular and subcellular levels to provide a scientific basis for the subsequent hepatotoxicity studies of MNPs.Entities:
Keywords: dysfunctions; hepatotoxicity; metallic nanoparticles; subcellular injury; toxicity outcome
Year: 2019 PMID: 31806972 PMCID: PMC6844216 DOI: 10.2147/IJN.S212907
Source DB: PubMed Journal: Int J Nanomedicine ISSN: 1176-9114
In Vivo Studies On The Liver Toxicity Of Metallic Nanoparticles (MNPs)
| Types | NP | Size (nm) | Subjects | Routes | Dose (mg·kg1·BW) | Time | Results | References |
|---|---|---|---|---|---|---|---|---|
| Monomeric MNPs | Cu | 80 | Male SD rats | Oral | 100; 200;400 | 7 days | Cu NPs induced liver injury by increased levels of IL-2, IL-6, IFN-γ, MIP-1, T-AOC, MDA through inflammation and oxidative stress; Cu NPs affected CYP450 activity and suppressed some nuclear receptors through the NF-κB signaling pathway. | |
| Ni | 50 | SD rats | Dorsal penile vein injection | 1; 10; 20 | Once at day 1 and once at day 14 | Ni NPs increased the liver coefficient in a dose-dependent manner. Both 1 mg/kg and 20 mg/kg doses of Ni NPs significantly increased serum albumin levels. Serum ALT levels decreased significantly in the 1 mg/kg group as well as total bilirubin levels with 10 mg/kg. Both total and direct bilirubin levels were reduced due to exposure to 20 mg/kg. | ||
| Ag | 10 | Male CD-1 (ICR) mice | Intravenous injection | 10 | 24 hrs | Ag NPs damaged the liver through extensive hepatocyte necrosis. It caused multiple bleeding around the biliary tract, including gallbladder wall and wall hemorrhage, accompanied by portal vein endothelial injury. | ||
| PVP-Ag | 30 | Male C57BL/6 mice (NAFLD) | Oral | 100;300 | 2 weeks | PVP-Ag NPs damaged the liver by inflammation and inhibiting fatty acid oxidation, and promoted the transformation of NAFLD to steatohepatitis. | ||
| PVP-Ag | 20–30 | Male SD rats | Oral | 50; 100;200 | 90 days | PVP-Ag NPs increased ROS production in a dose-dependent manner as a protective mechanism for cell survival and DNA fidelity. The activities of SOD and CAT were stimulated, as well as IRS-1, PKB, mTOR, p53, p21, and caspase-3. However, excessive ROS production might lead to the exhaustion of survival mechanism in rat liver, thereby enhancing autophagy, especially insulin resistance. | ||
| Au | – | C57BL/6 mice | Vein injection | 12;120; 1200 | 8 weeks | Preactivation of hepatic macrophages induced by gold nanorods (NR) significantly aggravated liver injury and disease activity in mice with experimental immune-mediated hepatitis. | ||
| Ti + Ag | Ti21 Ag<100 | Male Wistar rats | Gavage | 100 | 21 days | Ti NPs + Ag NPs reduced mitochondrial respiratory control ratio and had uncouple effects on the oxidative phosphorylation system. Ag NPs and Ti NPs have synergistic effects. When both NPs were exposed at the same time, the interference effect on mitochondrial function was more significant. | ||
| Metal oxide NPs | TiO2 | 21 | Male albino mice | Oral | 150 | 2 weeks | TiO2 NPs caused oxidative stress, inflammation, DNA damage, and potential apoptotic mechanisms. | |
| TiO2 | 12–18 (diameter) × 40–80 (length) | SD rats | Intraperitoneal injection | 0.5; 5;50 | 24 hrs | TiO2 NPs induced cell infiltration and hepatocyte necrosis in a dose-dependent manner. The activity of AST, ALT, LDH, and ALP was significantly higher than that of normal rats. | ||
| TiO2 | 21 | Male mats rats | Intratracheal instillation | 0.5;5; 50; 1.5; 15;150 | 4 days, a month, 3 months | After 4 days of intratracheal TiO2 NPs infusion, some pathological changes of liver tissue were observed, including necrosis of hepatocytes, increase of fibrosis, proliferation of histiocytes, and vasodilation. Injury effects were more obvious after 1 month and 3 months of infusion. | ||
| TiO2 | 21 | C57/BL6 mice | Oral | 250;500 | 14 days | Central venous congestion and hepatic sinus dilatation were observed in the liver tissue of rats poisoned by titanium dioxide NPs. Focal hemorrhage and coagulative necrosis of hepatocytes occur in the liver parenchyma. The proliferation of Kupffer cells was also observed. | ||
| TiO2 | 5;10;60;90 | ICR mice | Intraperitoneal injection | 5; 10;50; 100;150;20 | 60 days | Mitochondria of hepatocytes were slightly swollen after 60 days of exposure by TiO2. Concentrated chromatin and apoptotic cells (5 mg/kg), swollen mitochondria and vacuoles (10 mg/kg), collapsed nucleolus, dispersed chromatin and obvious apoptotic cells (50 mg/kg) appeared in the liver of mice. | ||
| ZnO | 40 | CD-ICR male mice | Oral | 250 | 7 weeks | ZnO NPs reduced the body weight, promoted the activity of serum glutamic-pyruvic transaminase, and increased neutrophil count and HGB in blood | ||
| NiO | 20 | Male Wistar rats | Intratracheal instillation | 0.015; 0.06;0.24 | Twice a week for 6 weeks | The wet weight of liver and liver coefficient increased in NiO exposed group. The pathological changes of liver were cellular edema, disappearance of hepatic sinuses, and binuclear hepatocytes. Total nitric oxide synthase (NOS) and inducible NOS activity increased, as well as NO content. The expression level of MT-1 was down-regulated while that of HO-1 was up-regulated. | ||
| NiO | 20 | Male Wistar rats | Intratracheal instillation | 0.015; 0.06; 0.24 | Twice a week for 6 weeks | NiO NPs increased the activity of liver-related enzymes, including ALT, GGT, AST, and ALP. The liver showed cellular edema, sinusoidal disappearance, infiltration by neutrophils and lymphocytes. NiO NPs increased the concentration of pro-inflammatory cytokines IL-1β and IL-6 and inhibited IL-4 and IL-10. |
Abbreviations: IL-2, interleukin-2; IL-6, interleukin-6; IFN-γ, interferon-γ; MIP-1, macrophage inflammatory protein-1; T-AOC, total-anti-oxidizing-capability; MDA, malonaldehyde; CYP450, P-450cytochrome; NF-κB, nuclear factor kappa-B; DNA, deoxyribonucleic acid; SOD, superoxide Dismutase; CAT, catalase; IRS-1, insulin receptor substrate-1; PKB, protein kinase B; mTOR, mammalian target of rapamycin; p53, protein 53; p21, cyclin-dependent kinase inhibitor 1A; NAFLD, nonalcoholic fatty liver disease; ALT, alanine aminotransferase; LDH, lactate dehydrogenase; ALP, alkaline phosphatase; HGB, hemoglobin; MT-1, metallothionein-1; HO-1, heme oxygenase-1; GGT, γ-glutamyl transpeptadase; IL-1β, interleukin-1β; IL-4, interleukin-4; IL-10, interleukin-10.
In Vitro Studies On The Liver Toxicity Of Metallic Nanoparticles (MNPs)
| Types | NPs | Size (nm) | Surface Modification | Cell | Dose | Time | Results | References |
|---|---|---|---|---|---|---|---|---|
| Monomeric MNPs | Au | 10; 30; 60 | – | HepG2 | 10ppb/10ppm | 16, 32 hrs | The excessive production of free radicals and ROS under the action of Au NPs lead to carbonylation of cellular proteins, lipid peroxidation, and DNA damage. The smaller the size of nanoparticles, the greater the effect. | |
| Au | 40±5 | SiO2& folate group | HepG2 | 2.5;5;10;20;40ppm | 48 hrs | GNRS@SiO2-FA enters cells through endocytosis, connects with tumor cells expressing high folic acid, and accumulates in cytoplasm. The cell viability decreased with the increase of nanomaterial concentration. | ||
| Ag | 10, 30–50 | PVP | HSCs | 20; 100; 250 μg/mL | 96 hrs | Reduction of cell survival rate exerted by AgNPs on HSCs were size-and dose-dependent, which was associated with mitochondrial damage and apoptosis. MMP-2 and MMP−9 were inhibited by AgNPs. | ||
| Ag | 16.3±1.8 (68.5%), 58.1±2.6 (31.5%) | Citrate | HepG2 | 0–100 μg/mL | 24 hrs | The IC50 value of citrate-coated AgNPs was 50 mg/L. Treatment with AgNPs resulted in cell membrane damage, decreased cell function and disordered antioxidant status. AgNPs exposure affected the respiratory chain of HepG2 cells. ROS production, GSH consumption, and SOD activity increased slightly but in a dose-independent manner. | ||
| Ag | 6.3±0.1 (93.3%), 28.58±0.4 (6.7%) | PVA | ||||||
| Ag | 20 | – | HepG2 | 50 μg/mL | 2;24 hrs | NPs lead to the ROS generation and oxidative stress due to mitochondrial damage and malfunction of respiratory chain. | ||
| Ag | 10; 50;100 | PVP | HepG2 | ≤10 μg/mL | 6; 12; 24hrs | The IC50 values of 10-, 50, and 100-nm AgNPs at 24 hrs post exposure were 5.1, 7.6, and 6.4 µg/mL, respectively. AgNP-induced hepatotoxicity is mediated by AgNP-induced LMP and inflammation-dependent caspase-1 activation. AgNPs induce autophagy and lysosomal membrane permeation, leading to inflammation-dependent caspase-1 activation of NLRP3. | ||
| Ag | 20 | – | C3A | 1–4 μg/cm2 | 24 hrs | LC50 lactate dehydrogenase: 2.5 μg/cm2. AgNPs affect the homeostasis of hepatocytes by reducing albumin release. At sublethal concentration, AgNPs were distributed in the cytoplasm and nucleus of hepatocytes. AgNPs induced changes in inflammatory mediators, accompanied by increased expression of IL-8/macrophage inflammatory protein 2, IL-1β and tumor necrosis factor-alpha, and increased release of IL-8 protein. | ||
| Ag | 2 | – | HepG2 | 0–20 μg/mL | 72 hrs | AgNPs inhibited the proliferation of HepG2 cells through induction of apoptosis with caspase-3 activation and PARP cleavage. AgNPs with dose-dependent manner significantly increased the apoptotic cell population (sub-G1). AgNP-induced apoptosis was found dependent on ROS and affecting of MAPKs and AKT signaling and DNA damage-mediated p53 phosphorylation to advance HepG2 cells apoptosis. | ||
| Ag | 28–35 | – | CHANG | 0–10 μg/mL | 24 hrs | The IC50 value was 4 μg/mL. AgNPs induced ROS generation and suppression of reduced GSH in human Chang liver cells. ROS generated by AgNPs resulted in DNA breaks, lipid membrane peroxidation, and protein carbonylation. cell viability decreased due to apoptosis. AgNPs induced a mitochondria-dependent apoptotic pathway via modulation of Bax and Bcl-2 expressions, resulting in the disruption of mitochondrial membrane potential (Δψm). | ||
| Ag | 5–10 | Cs/grape leaves aqueous extract (Cs/GLE) | HepG2 | 0.39–50% | - | Cs–Ag NPs induced mitochondrial intrinsic apoptotic pathway by upregulation of the expression of p53 and downregulation of the expression on Bcl-2 gene. | ||
| Ag | 16±2 | Reduced graphene oxide | CHANG;HepG2 | 5–50 μg/mL | 24 hrs | The rGO-Ag nanocomposite reduced cell viability and impaired cell membrane integrity of CHANG and HepG2 cells in a dose-dependent manner. It increased ROS and reduced mitochondrial membrane potential in both cells in a dose-dependent manner. The activity of lipid peroxide, superoxide dismutase, and catalase was increased and glutathione was reduced. The maximum DNA damage occurred at rGO–Ag nanocomposite (25 µg/mL) for 24 hrs. HepG2 cells are more sensitive to the effects of NPs. | ||
| Fe | 2–5 | Tannic complexes | HepG2 | 0–30 μM | 24 hrs | Fe-TA NPs can be taken up by HepG2.2.15 cells in concentration and in a time-dependent manner. A high uptake of Fe-TA NPs resulted in autophagic cell death. | ||
| Cu | 100±35 | – | Primary hepatocytes of E.coioides | 0; 2.4 mg Cu/L | 24 hrs | Cu NPs impaired structure of membrane and anti-oxidant defense system by increased ROS and lipid peroxidation. Increased ROS may impair mitochondrial bioenergetics and physiological functions. The release of mitochondrial cytochrome c into the cytosol activated caspases, triggering apoptosis. Oxidative stress activated apoptosis-related genes (p53, p38β, and TNF-α). | ||
| Metal oxide NPs | NiO | 24.05±2.9 | – | HepG2 | 25; 50; 200µg/mL | 24 hrs | NiO NPs induced oxidative stress, DNA damage, apoptosis, and transcriptome alterations. | |
| CuO | 50–70 (in length) | – | HepG2;SK-HEP-1 | 0; 10; 25; 50; 75; 100 μg/mL | 24 hrs | The IC50 for SK-Hep-1 and HepG2 cells was 25 μg/mL and 85 μg/mL, respectively. CuO NPs accumulated in cells, causing oxidative stress. SK-Hep-1 has a lower degree of differentiation and is more sensitive to toxicity. CuO-NP causes severe DNA strand breakage (70%) in SK-HEP-1 cells and causes DNA damage by increasing the level of gamma-h2ax. | ||
| ZnO | 71 | – | Catfish primary hepatocytes,HepG2 | 0–200 mg/L | 48 hrs | The IC50 values of nano-CuO and ZnO were 181.8 and 275.6 mg/L, respectively. Co3O4 had a stimulatory effect at 25 and 50 mg/L and inhibitory effect at 100 and 200 mg/L, respectively. This toxicity is caused not only by cell death caused by reactive oxygen species but also by damage to cell and mitochondrial membrane. | ||
| TiO2 | 42.3 | – | ||||||
| CuO | 28 | – | ||||||
| Co3O4 | 78.3 | – | ||||||
| TiO2 Degussa P25a 3:1 mixture of anatase and rutile | 21 | – | Primary rat hepatocytes | 0–1000 ppm | 72 hrs | The LC50 values of P25, anatase and rutile TiO2 nanoparticles were 74.13±9.72 ppm, 58.35±4.76 ppm, and 106.81±11.24ppm, respectively. Prolonged exposure of hepatocytes to TiO2 NPs decreased two main specific functions of hepatocyte- urea synthesis and albumin synthesis. The exposure of hepatocytes to 50 ppm of P25 and anatase resulted in relatively highest ROS production while exposure to the same concentration of rutile demonstrated lesser ROS production. | ||
| TiO2 Pure rutile | 50 | – | ||||||
| TiO2 Pure anatase | 50 | – | ||||||
| SPION | 10 | – | Primary rat hepatocytes | 0–400 μg/mL | 48 hrs | The LD50 values were calculated as 328.51 ± 18.25 and 319.79 ± 25.73 for one-shot and cumulative treatment styles, respectively. The time-dependent ROS production data from the current study illustrates that ROS can be used as an early and potent diagnostic marker for SPION-induced toxicity as well as other nanotoxicological inquiries in the liver. | ||
| Fe3O4-TiO2 | 20–25 | – | HL-7702 | Ti: 0; 6.25; 15.625 25 µg/cm2 | 12 hrs | Fe3O4-TiO2 NPs induced cellular ROS generation, reduced cell viability, and induced apoptosis in a dose-dependent manner in HL7702 cells. Mitochondrial membrane was damaged and cytochrome c was released, followed by regulation of apoptosis-related proteins. |
Abbreviations: HSCs, hepatic stellate cells; MMP, matrix metalloprotein; IC50, half-maximal inhibitory concentration; PVA, Polyvinyl alcohol; GSH, glutathione; NLRP3:NLRs, pyrin domain containing 3; LC50, median lethal concentration; MAPK, mitogen-activated protein kinase; AKT, protein kinase B; CHANG, human Chang liver cells; LD50, median lethal dose; SPION, superparamagnetic iron oxide nanoparticles.
Figure 1Different death mechanisms of liver cells are involved in the pathogenesis of liver injury induced by MNPs. Liver damage caused by MNPs is associated with oxidative damage, inflammatory response, and liver fibrosis in the liver. Apoptosis, autophagy, pyroptosis, and necrosis are all pathways of hepatocyte death. ROS induced by MNPs is responsible for the lipid peroxidation injury of the hepatic subcellular organelles. Apoptosis is considered as type I programmed cell death and mainly mediated by endogenous mitochondrial pathway and exogenous death receptor pathway. Mitochondrial ROS inhibited Bcl-2, and Fas-related death domain proteins (FADD) were activated, all of which eventually activated caspase 3 or caspase 7. Autophagy cell death is a programmed cell death different from apoptosis with initiation, nucleation of autophagosomes, phagosome expansion and completion, and autolysosome docking. Mitochondria and endoplasmic reticulum oxidative stress cause changes in the upstream molecules of autophagy and regulate autophagy-related (Atg) molecules. Pyroptosis is a form of inflammatory cell death that characterized by caspase-1-dependent formation of plasma membrane pores, and mainly manifested by lysosome rupture, ROS production and the activation of inflammation, leading to the release of pro-inflammatory cytokines and cell lysis. Necrosis is due to the production of ROS or instability of lysosome, release of calpain, and decrease of ATP level. The characteristics of necrosis include plasma membrane rupture, mitochondrial swelling, lysosome rupture, and intracellular contents release. Cell necrosis leads to inflammation that is not related to caspase cascade.